Reduction of renal transport maximum for glucose by inhibition of Na +-glucose cotransporter suppresses blood glucose elevation in dogs

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 1, 2006, Pages 114-118

  Ueta, Kiichiro ^a   Yoneda, Hikaru ^a   Oku, Akira ^a   Nishiyama, Shinsuke ^a   Saito, Akira ^a   Arakawa, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Antidiabetic agent; Dog; Glucose tolerance test; Na+ glucose cotransporter (SGLT); T 1095; Transport maximum for glucose (TmG)

Indexed keywords

3 (5 BENZOFURANYL) 1 [2 HYDROXY 6 [6 O (METHOXYCARBONYL) BETA DEXTRO GLUCOPYRANOSYL] 4 METHYLPHENYL] 1 PROPANONE; GLUCOSE; SODIUM GLUCOSE COTRANSPORTER; T 1095A; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE URINE LEVEL; GLUCOSURIA; HYPERGLYCEMIA; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST;

ANIMALS; BLOOD GLUCOSE; CARBONATES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSIDES; HYPERGLYCEMIA; KIDNEY; MALE; POSTPRANDIAL PERIOD; SODIUM; SODIUM-GLUCOSE TRANSPORT PROTEINS;

EID: 29844438479     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.114     Document Type: Article

References (12)

1. Lebovitz E. L., "Joslin's Diabetes Mellitus," 13th ed., ed. by Kahn C. R., Weir G. C., Lea & Febiger, Philadelphia, 1994, pp. 508-529.
2. Oku A., Ueta K., Arakawa K., Ishihara T., Nawano M., Kuronuma Y., Matsumoto M., Saito A., Tsujihara K., Anai M., Asano T., Kanai Y., Endou H., Diabetes, 48, 1794-1800 (1999).
3. Tsujihara K., Hongu M., Saito K., Kawanishi H., Kuriyama K., Matsumoto M., Oku A., Ueta K., Tsuda M., Saito A., J. Med. Chem., 42, 5311-5324 (1999).
4. Adachi T., Yasuda K., Okamoto Y., Shihara N., Oku A., Ueta K., Kitamura K., Saito A., Iwakura T., Yamada Y., Yano H., Seino Y., Tsuda K., Metabolism, 49, 990-995 (2000).
5. Oku A., Ueta K., Arakawa K., Kano-Ishihara T., Matsumoto T., Adachi T., Yasuda K., Tsuda K., Ikezawa K., Saito A., Jpn. J. Pharmacol., 84, 351-354 (2000).
6. Arakawa K., Ishihara T., Oku A., Nawano M., Ueta K., Kitamura K., Matsumoto M., Saito A., Br. J. Pharmacol., 132, 578-586 (2001).
7. Nawano M., Oku A., Ueta K., Umebayashi I., Ishihara T., Arakawa K., Saito A., Anai M., Kikuchi M., Asano T., Am. J. Physiol. Endocrinol. Metab., 278, E535-E543 (2000).
8. Oku A., Ueta K., Nawano M., Arakawa K., Ishihara K.-T. Matsumoto M., Saito A., Tsujihara K., Anai M., Asano T., Eur. J. Pharmacol., 391, 183-192 (2000).
9. Ueta K., Ishihara T., Matsumoto Y., Oku A., Nawano M., Fujita T., Saito A., Arakawa K., Life Sci., 76, 2655-2668 (2005).
10. Silverman M., Turner R. J., "Handbook of Physiology, Section 8: Renal Physiology," Vol. 2, ed. by Windharger E. E., Oxford Univ. Press, Oxford, 1992, pp. 2017-2038.
11. Deetjen P., Baeyer H. V., Drexel H., "Textbook of Nephrology," 3rd ed., Vol. 1, ed. by Massry S. G., Glassock R. J., Williams & Wilkins, Baltimore, 1995, pp. 90-94.
12. Oku A., Ueta K., Arakawa K., Kano-Ishihara T., Matsumoto, M., Adachi T., Yasuda K., Tsuda K., Saito A., Biol. Pharm. Bull., 23, 1434-1437 (2000).